Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Defensins are a family of secreted antimicrobial peptides proposed to directly interfere with bacterial membranes. Here we show a functional analysis of the novel beta-defensin
DEFB123
. A peptide comprising the beta-defensin core region was synthesized and used for our analysis. Like other beta-defensins,
DEFB123
exerted antimicrobial activity against a broad spectrum of Gram-positive and Gram-negative bacteria, which was assessed by microbroth dilution assay and radial diffusion zone assay. In addition, the peptide showed
lipopolysaccharide
(
LPS
)-binding activity in a Limulus amoebocyte lysate (LAL) assay. Moreover,
DEFB123
prevented
LPS
-induced tumor necrosis factor (TNF)-alpha secretion in a murine monocyte cell line (RAW264.7). Accordingly,
DEFB123
abolished
LPS
-mediated MAPK induction in these cells. Protection against
LPS
-mediated effects was then investigated in a murine model of acute sepsis. Our experiments show that synthetic beta-defensin
DEFB123
prevents
LPS
-induced mortality in C57BL/6 mice in a therapeutic approach. We propose that the physiological role of beta-defensins may include interference with
LPS
-action on macrophages, a function formerly thought to be restricted to the family of cathelicidins, a structurally unrelated group of antimicrobial peptides.
...
PMID:The novel beta-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo. 1679 May 30